These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 10389906

  • 1. Expression of transforming growth factor beta type II receptors in head and neck squamous cell carcinoma.
    Muro-Cacho CA, Anderson M, Cordero J, Muñoz-Antonia T.
    Clin Cancer Res; 1999 Jun; 5(6):1243-8. PubMed ID: 10389906
    [Abstract] [Full Text] [Related]

  • 2. Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.
    Muro-Cacho CA, Rosario-Ortiz K, Livingston S, Muñoz-Antonia T.
    Clin Cancer Res; 2001 Jun; 7(6):1618-26. PubMed ID: 11410498
    [Abstract] [Full Text] [Related]

  • 3. Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma.
    Paterson IC, Matthews JB, Huntley S, Robinson CM, Fahey M, Parkinson EK, Prime SS.
    J Pathol; 2001 Apr; 193(4):458-67. PubMed ID: 11276004
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Transforming growth factor beta receptors in verrucous and squamous cell carcinoma.
    Anderson M, Muro-Cacho C, Cordero J, Livingston S, Muñoz-Antonia T.
    Arch Otolaryngol Head Neck Surg; 1999 Aug; 125(8):849-54. PubMed ID: 10448730
    [Abstract] [Full Text] [Related]

  • 7. Functional characterization of transforming growth factor beta type II receptor mutants in human cancer.
    De M, Yan W, de Jonge RR, Garrigue-Antar L, Vellucci VF, Reiss M.
    Cancer Res; 1998 May 01; 58(9):1986-92. PubMed ID: 9581843
    [Abstract] [Full Text] [Related]

  • 8. [The expression in situ of transforming growth factor beta s, their receptors and TGF beta-receptor interacting protein-1 in nasopharygneal carcinoma].
    Bin L, Hu C, Zhan F.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Aug 01; 34(4):210-2. PubMed ID: 12764773
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV, Gama P, Wen X, Demopoulos R, Munger JS, Carcangiu ML, Reiss M, Gold LI.
    Cancer Res; 2002 May 15; 62(10):2778-90. PubMed ID: 12019154
    [Abstract] [Full Text] [Related]

  • 11. The spatiotemporal expression of TGF-beta1 and its receptors during periosteal chondrogenesis in vitro.
    Mizuta H, Sanyal A, Fukumoto T, Fitzsimmons JS, Matsui N, Bolander ME, Oursler MJ, O'Driscoll SW.
    J Orthop Res; 2002 May 15; 20(3):562-74. PubMed ID: 12038632
    [Abstract] [Full Text] [Related]

  • 12. Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.
    Báez A, Cantor A, Fonseca S, Marcos-Martinez M, Mathews LA, Muro-Cacho CA, Muñoz-Antonia T.
    Clin Cancer Res; 2005 May 01; 11(9):3191-7. PubMed ID: 15867212
    [Abstract] [Full Text] [Related]

  • 13. Human malignant thyroid tumors displayed reduced levels of transforming growth factor beta receptor type II messenger RNA and protein.
    Lazzereschi D, Ranieri A, Mincione G, Taccogna S, Nardi F, Colletta G.
    Cancer Res; 1997 May 15; 57(10):2071-6. PubMed ID: 9158007
    [Abstract] [Full Text] [Related]

  • 14. Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma.
    Mukunyadzi P, Liu K, Hanna EY, Suen JY, Fan CY.
    Mod Pathol; 2003 Aug 15; 16(8):796-801. PubMed ID: 12920224
    [Abstract] [Full Text] [Related]

  • 15. The TGF-beta type III receptor is localized to the medial edge epithelium during palatal fusion.
    Cui XM, Shuler CF.
    Int J Dev Biol; 2000 Jun 15; 44(4):397-402. PubMed ID: 10949049
    [Abstract] [Full Text] [Related]

  • 16. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G, Schwarz RE, Higgins L, McEnroe G, Chakravarty S, Dugar S, Reiss M.
    Cancer Res; 2004 Aug 01; 64(15):5200-11. PubMed ID: 15289325
    [Abstract] [Full Text] [Related]

  • 17. TGF-beta receptor types I and II are differentially expressed during corneal epithelial wound repair.
    Zieske JD, Hutcheon AE, Guo X, Chung EH, Joyce NC.
    Invest Ophthalmol Vis Sci; 2001 Jun 01; 42(7):1465-71. PubMed ID: 11381048
    [Abstract] [Full Text] [Related]

  • 18. Expression of TGF-beta 1 protein and mRNA and the effect on the tissue remodeling in laryngeal carcinomas.
    Hagedorn H, Sauer U, Schleicher E, Nerlich A.
    Anticancer Res; 1999 Jun 01; 19(5B):4265-72. PubMed ID: 10628385
    [Abstract] [Full Text] [Related]

  • 19. Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1).
    Farley J, Gray K, Nycum L, Prentice M, Birrer MJ, Jakowlew SB.
    Gynecol Oncol; 2000 Aug 01; 78(2):113-22. PubMed ID: 10926789
    [Abstract] [Full Text] [Related]

  • 20. Expression of TGF-beta1 and its receptor genes (TbetaR I, TbetaR II, and TbetaR III-betaglycan) in peripheral blood leucocytes in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome.
    Jachec W, Foremny A, Domal-Kwiatkowska D, Smolik S, Tomasik A, Mazurek U, Wodniecki J.
    Int J Mol Med; 2008 Jan 01; 21(1):99-107. PubMed ID: 18097622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.